Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Modi Ventures is a venture capital firm founded in 2022 and based in the United States. The firm specializes in early-stage investments that focus on the intersection of technology and biology, particularly in the emerging bioeconomy. Modi Ventures aims to shape this sector by investing in technology platforms that have a significant impact on health outcomes.
As of now, Modi Ventures manages approximately $134 million in assets under management (AUM) across two funds. The first fund, Tech+Bio Fund I, closed at $32 million in 2023, while the second fund, Fund II, raised $88 million in July 2025, indicating strong institutional interest and an oversubscribed round. The firm operates from its headquarters at TMC Helix Park, located within the Texas Medical Center in Houston, which is recognized as the world's largest medical ecosystem.
Modi Ventures has a portfolio of eight companies, reflecting its commitment to investing in innovative solutions that enhance health outcomes. The firm has established partnerships with notable co-investors, including Khosla Ventures and Section 32, which further strengthens its position in the biotech and healthcare sectors.
Modi Ventures targets investments in the bioeconomy, focusing on sectors such as biotech, healthcare, and artificial intelligence. The firm primarily invests at the pre-seed, seed, and seed-plus stages, with check sizes that align with early-stage funding requirements. The investment strategy emphasizes technology platforms that leverage advancements in artificial intelligence, microfluidics, multiomics, precision medicine, synthetic biology, gene editing, and living therapies.
The firm seeks to partner with founders and funds that are at the forefront of these innovative areas, aiming to support solutions that significantly impact health outcomes. Modi Ventures looks for entrepreneurs who demonstrate a strong vision and capability to execute their ideas, particularly in the context of developing technologies that can transform healthcare delivery and patient outcomes.
Modi Ventures' thesis revolves around the convergence of technology and biology, which is increasingly relevant in today's healthcare landscape. The firm is committed to identifying and nurturing early-stage companies that are pioneering advancements in these fields, thereby contributing to the evolution of the bioeconomy.
Modi Ventures has invested in a diverse array of companies within the biotech and healthcare sectors. Notable portfolio companies include:
This portfolio reflects Modi Ventures' commitment to investing in companies that are leveraging technology to address significant health challenges. The firm’s focus on early-stage investments allows it to play a crucial role in the development of groundbreaking therapies and solutions in the healthcare sector.
Sahir Ali: Founder and General Partner. Sahir has a background in AI, medical imaging, and cancer research, with extensive experience in enterprise technology and cloud computing.
Amir Ali: Senior Partner and COO. Amir evaluates investments and mentors entrepreneurs, also serving as Principal at Modi Family Office.
Ben Rosenbluth: Investment Associate. Ben supports the investment team in evaluating potential portfolio companies.
Evangelia Tzika: Investment Associate. Evangelia assists in deal sourcing and due diligence processes.
Tricia Carrigan: Translational Science Advisor. Tricia provides expertise in translating scientific advancements into viable business opportunities.
Kiley Giebel: Associate. Kiley contributes to the investment team by analyzing market trends and potential investments.
J.D. Swartz: Head of Communications. J.D. manages the firm's communications strategy and public relations efforts.
To pitch to Modi Ventures, founders should submit their proposals through the firm's website at modivc.com. The pitch deck should include a clear overview of the technology, market potential, and the founding team's qualifications. Founders are encouraged to highlight any unique aspects of their approach and how it aligns with the firm's focus on the bioeconomy.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In July 2025, Modi Ventures announced the close of its second fund, raising $88 million, which was oversubscribed. This fund focuses on investments at the intersection of AI and biology, reflecting the firm's commitment to the bioeconomy.
Modi Ventures has been actively deploying capital into AI and bio crossover deals, indicating a strong momentum in its investment strategy. The firm has established partnerships with top-tier life science and tech funds, enhancing its co-investment relationships.
Recent reports highlight Modi Ventures' growing influence in the biotech sector, with a portfolio that includes innovative companies like Proxima and Exciva Therapeutics, which are making strides in drug discovery and therapeutic development.
What are Modi Ventures' investment criteria?
Modi Ventures focuses on early-stage investments in the bioeconomy, particularly in sectors such as biotech, healthcare, and artificial intelligence. The firm looks for technology platforms that leverage advancements in areas like microfluidics, multiomics, and gene editing.
How can founders apply or pitch to Modi Ventures?
Founders can pitch their ideas through the firm's website at modivc.com. It is advisable to include a clear outline of the technology, market potential, and team background in the pitch deck.
What makes Modi Ventures different from other venture capital firms?
Modi Ventures distinguishes itself by focusing specifically on the intersection of technology and biology, investing in innovative solutions that enhance health outcomes. The firm has a strong network of co-investors and provides strategic mentorship to its portfolio companies.
What is the geographic scope of Modi Ventures' investments?
The firm primarily invests in the United States, targeting early-stage companies that are developing technologies in the bioeconomy.
What is the typical check size for investments?
While specific check sizes are not disclosed, Modi Ventures invests at the pre-seed, seed, and seed-plus stages, which typically involve smaller initial investments that can grow as companies develop.
What kind of post-investment involvement does Modi Ventures have?
Modi Ventures provides mentorship and guidance to its portfolio companies, leveraging the team's extensive backgrounds in AI, medical imaging, and cancer research to support entrepreneurs in their growth journey.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.